Catalyst Wire Dossier Catalyst Wire Dossier

Anticancer medication combined with immune cell therapy (name undisclosed)

· Hangzhou Converd Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anticancer medication combined with immune cell therapy (name undisclosed), covering 2018-03-26 to 2018-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer [Phase 1]

See pricing